Clinical Trial: Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as Postoperative Adjuvant Regimens in Patients With Resectable Gastric Cancer/Adenocarcinoma of the Esophagogastric Junction After Radical Surgery

U.S., Aug. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07149181) titled 'Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as Postoperative Adjuvant Regimens in Patients With Resectable Gastric Cancer/Adenocarcinoma of the Esophagogastric Junction After Radical Surgery' on Aug. 23.

Brief Summary: This study is to evaluate the efficacy and safety of chemotherapy combined with or without immunotherapy as postoperative adjuvant regimens in patients with resectable gastric cancer/adenocarcinoma of the esophagogastric junction after radical surgery

Study Start Date: Aug. 31

Study Type: INTERVENTIONAL

Condition: Gastric / Gastroesophageal Junction Adenocarcinoma

Inte...